Violet Darrow, APRN-CNS | |
1145 S Utica Ave, Suite 460, Tulsa, OK 74104 | |
(918) 579-5749 | |
(918) 579-5762 |
Full Name | Violet Darrow |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 10 Years |
Location | 1145 S Utica Ave, Tulsa, Oklahoma |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124425046 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
364S00000X | Clinical Nurse Specialist | 93309 (Oklahoma) | Secondary |
363LA2100X | Nurse Practitioner - Acute Care | 93309 (Oklahoma) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Jane Phillips Memorial Medical Center, Inc | Bartlesville, OK | Hospital |
St John Owasso | Owasso, OK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Hospitalist Medicine Physicians Of Texas Pllc | 3476688318 | 951 |
News Archive
HemaQuest Pharmaceuticals announced today that it has initiated the Company's Phase 2 clinical trial evaluating its proprietary HQK-1004 therapy for the treatment of lymphomas and related cancers associated with Epstein-Barr virus (EBV) infection. These EBV-related cancers have poor prognoses and short patient survival. Currently available cancer therapies are typically much less effective in patients with EBV-related lymphoid malignancies than in patients who have similar cancers not infected with the virus.
A number of news organizations are detailing the conflicts and positions of certain lawmakers in the ongoing health overhaul effort.
The National Institutes of Health has awarded a R01 grant to a multi-institutional team to develop and evaluate a pregnancy-specific Artificial Pancreas in a sequence of in-clinic and transitional environment clinical trials.
Latino children have the highest uninsured rate in the United States. However, new study findings in the March issue of Health Affairs show parent mentors are highly effective at providing uninsured Latino children with health insurance coverage.
› Verified 3 days ago
Entity Name | Tulsa Hospitalists Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659397081 PECOS PAC ID: 5698664894 Enrollment ID: O20040315000661 |
News Archive
HemaQuest Pharmaceuticals announced today that it has initiated the Company's Phase 2 clinical trial evaluating its proprietary HQK-1004 therapy for the treatment of lymphomas and related cancers associated with Epstein-Barr virus (EBV) infection. These EBV-related cancers have poor prognoses and short patient survival. Currently available cancer therapies are typically much less effective in patients with EBV-related lymphoid malignancies than in patients who have similar cancers not infected with the virus.
A number of news organizations are detailing the conflicts and positions of certain lawmakers in the ongoing health overhaul effort.
The National Institutes of Health has awarded a R01 grant to a multi-institutional team to develop and evaluate a pregnancy-specific Artificial Pancreas in a sequence of in-clinic and transitional environment clinical trials.
Latino children have the highest uninsured rate in the United States. However, new study findings in the March issue of Health Affairs show parent mentors are highly effective at providing uninsured Latino children with health insurance coverage.
› Verified 3 days ago
Entity Name | Morad El-raheb Md Inc Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1194741520 PECOS PAC ID: 7719987254 Enrollment ID: O20070105000267 |
News Archive
HemaQuest Pharmaceuticals announced today that it has initiated the Company's Phase 2 clinical trial evaluating its proprietary HQK-1004 therapy for the treatment of lymphomas and related cancers associated with Epstein-Barr virus (EBV) infection. These EBV-related cancers have poor prognoses and short patient survival. Currently available cancer therapies are typically much less effective in patients with EBV-related lymphoid malignancies than in patients who have similar cancers not infected with the virus.
A number of news organizations are detailing the conflicts and positions of certain lawmakers in the ongoing health overhaul effort.
The National Institutes of Health has awarded a R01 grant to a multi-institutional team to develop and evaluate a pregnancy-specific Artificial Pancreas in a sequence of in-clinic and transitional environment clinical trials.
Latino children have the highest uninsured rate in the United States. However, new study findings in the March issue of Health Affairs show parent mentors are highly effective at providing uninsured Latino children with health insurance coverage.
› Verified 3 days ago
Entity Name | Thi Specialists Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952763922 PECOS PAC ID: 6103118153 Enrollment ID: O20160712001228 |
News Archive
HemaQuest Pharmaceuticals announced today that it has initiated the Company's Phase 2 clinical trial evaluating its proprietary HQK-1004 therapy for the treatment of lymphomas and related cancers associated with Epstein-Barr virus (EBV) infection. These EBV-related cancers have poor prognoses and short patient survival. Currently available cancer therapies are typically much less effective in patients with EBV-related lymphoid malignancies than in patients who have similar cancers not infected with the virus.
A number of news organizations are detailing the conflicts and positions of certain lawmakers in the ongoing health overhaul effort.
The National Institutes of Health has awarded a R01 grant to a multi-institutional team to develop and evaluate a pregnancy-specific Artificial Pancreas in a sequence of in-clinic and transitional environment clinical trials.
Latino children have the highest uninsured rate in the United States. However, new study findings in the March issue of Health Affairs show parent mentors are highly effective at providing uninsured Latino children with health insurance coverage.
› Verified 3 days ago
Entity Name | Hospitalist Medicine Physicians Of Texas Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629307095 PECOS PAC ID: 3476688318 Enrollment ID: O20180326002260 |
News Archive
HemaQuest Pharmaceuticals announced today that it has initiated the Company's Phase 2 clinical trial evaluating its proprietary HQK-1004 therapy for the treatment of lymphomas and related cancers associated with Epstein-Barr virus (EBV) infection. These EBV-related cancers have poor prognoses and short patient survival. Currently available cancer therapies are typically much less effective in patients with EBV-related lymphoid malignancies than in patients who have similar cancers not infected with the virus.
A number of news organizations are detailing the conflicts and positions of certain lawmakers in the ongoing health overhaul effort.
The National Institutes of Health has awarded a R01 grant to a multi-institutional team to develop and evaluate a pregnancy-specific Artificial Pancreas in a sequence of in-clinic and transitional environment clinical trials.
Latino children have the highest uninsured rate in the United States. However, new study findings in the March issue of Health Affairs show parent mentors are highly effective at providing uninsured Latino children with health insurance coverage.
› Verified 3 days ago
Entity Name | Cogent Healthcare Of Texas Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1992722953 PECOS PAC ID: 8628076924 Enrollment ID: O20210209000102 |
News Archive
HemaQuest Pharmaceuticals announced today that it has initiated the Company's Phase 2 clinical trial evaluating its proprietary HQK-1004 therapy for the treatment of lymphomas and related cancers associated with Epstein-Barr virus (EBV) infection. These EBV-related cancers have poor prognoses and short patient survival. Currently available cancer therapies are typically much less effective in patients with EBV-related lymphoid malignancies than in patients who have similar cancers not infected with the virus.
A number of news organizations are detailing the conflicts and positions of certain lawmakers in the ongoing health overhaul effort.
The National Institutes of Health has awarded a R01 grant to a multi-institutional team to develop and evaluate a pregnancy-specific Artificial Pancreas in a sequence of in-clinic and transitional environment clinical trials.
Latino children have the highest uninsured rate in the United States. However, new study findings in the March issue of Health Affairs show parent mentors are highly effective at providing uninsured Latino children with health insurance coverage.
› Verified 3 days ago
Entity Name | Tulsa Hospital Medicine Physicians Group, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144982711 PECOS PAC ID: 7214327832 Enrollment ID: O20211214000389 |
News Archive
HemaQuest Pharmaceuticals announced today that it has initiated the Company's Phase 2 clinical trial evaluating its proprietary HQK-1004 therapy for the treatment of lymphomas and related cancers associated with Epstein-Barr virus (EBV) infection. These EBV-related cancers have poor prognoses and short patient survival. Currently available cancer therapies are typically much less effective in patients with EBV-related lymphoid malignancies than in patients who have similar cancers not infected with the virus.
A number of news organizations are detailing the conflicts and positions of certain lawmakers in the ongoing health overhaul effort.
The National Institutes of Health has awarded a R01 grant to a multi-institutional team to develop and evaluate a pregnancy-specific Artificial Pancreas in a sequence of in-clinic and transitional environment clinical trials.
Latino children have the highest uninsured rate in the United States. However, new study findings in the March issue of Health Affairs show parent mentors are highly effective at providing uninsured Latino children with health insurance coverage.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Violet Darrow, APRN-CNS 1145 S Utica Ave, Suite 460, Tulsa, OK 74104 Ph: (918) 579-5749 | Violet Darrow, APRN-CNS 1145 S Utica Ave, Suite 460, Tulsa, OK 74104 Ph: (918) 579-5749 |
News Archive
HemaQuest Pharmaceuticals announced today that it has initiated the Company's Phase 2 clinical trial evaluating its proprietary HQK-1004 therapy for the treatment of lymphomas and related cancers associated with Epstein-Barr virus (EBV) infection. These EBV-related cancers have poor prognoses and short patient survival. Currently available cancer therapies are typically much less effective in patients with EBV-related lymphoid malignancies than in patients who have similar cancers not infected with the virus.
A number of news organizations are detailing the conflicts and positions of certain lawmakers in the ongoing health overhaul effort.
The National Institutes of Health has awarded a R01 grant to a multi-institutional team to develop and evaluate a pregnancy-specific Artificial Pancreas in a sequence of in-clinic and transitional environment clinical trials.
Latino children have the highest uninsured rate in the United States. However, new study findings in the March issue of Health Affairs show parent mentors are highly effective at providing uninsured Latino children with health insurance coverage.
› Verified 3 days ago
Jennifer Christa Pimentel, ARNP, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6565 S Yale Ave Ste 209, Tulsa, OK 74136 Phone: 918-392-4550 Fax: 918-392-4551 | |
Casie Nicole Brim, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1919 S Wheeling Ave, Suite 606, Tulsa, OK 74104 Phone: 918-748-7676 Fax: 918-293-3130 | |
Jared Qualls, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1145 S Utica Ave, Suite 460, Tulsa, OK 74104 Phone: 918-579-5749 Fax: 918-579-5762 | |
Adekemi Taiwo, APRN - CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: Hillcrest South Medical Plaza, 8803 S. 101 St E. Ave. Suite 350, Tulsa, OK 74133 Phone: 918-615-3750 | |
Stephanie Ann Adame, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 12697 E 51st St, Tulsa, OK 74146 Phone: 918-505-3200 | |
Mrs. Susan Elaine Graham, DNP, APRN, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2408 E 81st St Ste 900, Tulsa, OK 74137 Phone: 918-319-5021 Fax: 918-477-5853 | |
Lisa Michele Sample, AG-ACNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6161 S Yale Ave, Tulsa, OK 74136 Phone: 918-494-2200 |